Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial chemoreceptors, most commonly referred to as **methyl-accepting chemotaxis proteins** (MCPs), are signaling receptors found in bacteria and archaea that detect chemical gradients in the environment and initiate chemotactic movement[5][6][7]. These receptors are typically homodimeric, elongated proteins composed of functional modules for transmembrane sensing, signal conversion, and kinase control[5]. MCPs assemble into highly ordered hexagonal arrays that connect with the **histidine kinase CheA** and the coupling protein **CheW**, enabling precise transmembrane signaling and adaptation[1][2][4]. They mediate *chemotaxis*, allowing cells to move toward favorable conditions or away from harmful stimuli by transmitting sensory signals that regulate flagellar motor activity[7][6]. MCPs are pivotal for environmental adaptability in motile microorganisms and are conserved across diverse bacterial and archaeal species[3][4]. While central to microbial physiology, chemoreceptors themselves are not typical therapeutic targets for drug development due to their absence in humans and their structural and evolutionary diversity[3][5].\n**Note:** The query "Microbial Chemoreceptors" is overly broad and does not specify an individual protein or receptor class, and is not considered a canonical therapeutic target. The canonical singular name is "Methyl-accepting chemotaxis protein" (MCP).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyl-accepting chemotaxis protein (MCP).